A Trial of Vigil for Participants With Ovarian Cancer

Clinical trial NCT02346747 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02346747
Sponsor: Gradalis, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Ovarian Neoplasms

Start date: 2015-02-01
Primary completion: 2028-12-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.